HomeCGTX • NASDAQ
add
Cognition Therapeutics Inc
Previous close
$0.44
Day range
$0.42 - $0.44
Year range
$0.31 - $2.95
Market cap
27.22M USD
Avg Volume
574.06K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.72M | -29.40% |
Net income | -7.84M | 3.67% |
Net profit margin | — | — |
Earnings per share | -0.17 | 37.04% |
EBITDA | -10.70M | 29.46% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 25.01M | -16.42% |
Total assets | 30.23M | -14.02% |
Total liabilities | 11.48M | 7.44% |
Total equity | 18.75M | — |
Shares outstanding | 61.97M | — |
Price to book | 1.42 | — |
Return on assets | -92.74% | — |
Return on capital | -154.84% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -7.84M | 3.67% |
Cash from operations | -8.38M | -53.63% |
Cash from investing | -1.00K | 96.67% |
Cash from financing | 11.38M | 366.63% |
Net change in cash | 3.00M | 198.39% |
Free cash flow | -7.68M | 6.73% |
About
Founded
Jan 1, 2007
Headquarters
Website
Employees
25
